Furthermore, evidence suggests that cases with a high infiltration of PD-1(+) tumor-infiltrating macrophages and co-expression of PD-1 and PD-L1 are associated with an inferior clinical outcome [12, 15]. This evidence concerns the gene PDCD1 and neoplasm.